Efficacy of Botulinum Toxin Type A for the Treatment of Non-neurogenic Urinary Urge Incontinence

Inclusion Criteria: * Female subjects, greater than 17 years of age * Written informed consent has been obtained * Ability to follow study instructions and likely to complete all required visits * Written authorization for Use and Release of Health and Research Study Information has been obtained * Subject meets the following criteria: clinical diagnosis of urinary urge incontinence with resistance to or intolerance of anticholinergic medication * Anticholinergic medications allowed * Willingness and ability to use self-catheterization if necessary Exclusion Criteria: * Uncontrolled clinically significant medical condition other than the condition under evaluation * Known allergy or sensitivity to any of the components in the study medication * Females with a positive pregnancy test, or who are breast-feeding, planning a pregnancy during the study, who think that they may be pregnant at the start of the study * Concurrent participation in another investigational drug or device study * Treatment with botulinum toxin of any serotype for urological condition prior to enrolment in study (if applicable) * Any medical condition that may put the subject at increased risk with exposure to botulinum toxin A including diagnosed myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, or any other disorder that might interfere with neuromuscular function * Any condition or situation that, in the investigator's opinion, may put the subject at significant risk, confoun…